A new letter in the British Medical Journal highlights several experts who claim that the FDA's oversight of the COVID-19 "vaccine" clinical trials was "grossly inadequate" and led to an "endangering of public health."
A new letter in the British Medical Journal highlights several experts who claim that the FDA's oversight of the COVID-19 "vaccine" clinical trials was "grossly inadequate" and led to an "endangering of public health."